comparemela.com

Latest Breaking News On - Growth rank - Page 9 : comparemela.com

Jim Simons Trims Stake in Nicholas Financial Inc

On December 29, 2023, Renaissance Technologies, led by Jim Simons (Trades, Portfolio), reported a reduction in its holdings of Nicholas Financial Inc (NASDAQ:NICK). The transaction involved the sale of 8,025 shares at a price of $6.90 per share.

Jim Simons Adjusts Position in Heidrick & Struggles International Inc

Overview of Jim Simons (Trades, Portfolio)'s Recent Trade Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently adjusted its holdings in Heidrick & Struggles International Inc (NASDAQ:HSII), a prominent leadership advisory firm. On December 29, 2023, the firm reduced its position in HSII, signaling a strategic shift in its investment portfolio. This move by one of the world's most successful hedge funds has caught the attention of investors and market analysts alike, as they seek to understand the implications of this transaction.

Mairs and Power Adjusts Position in Tennant Co

Mairs and Power (Trades, Portfolio), a Minnesota-based investment firm, has recently made a notable adjustment to its investment portfolio by reducing its stake in Tennant Co (NYSE:TNC). Mairs and Power (Trades, Portfolio) is renowned for its disciplined long-term investment approach, managing three mutual funds with a focus on companies that exhibit consistent growth, strong returns on invested capital, and durable competitive advantages.

PRIMECAP Management Adjusts Stake in United Airlines Holdings Inc

PRIMECAP Management (Trades, Portfolio), a notable investment firm, has recently altered its investment in United Airlines Holdings Inc (NASDAQ:UAL). After this transaction, PRIMECAP Management (Trades, Portfolio) holds a total of 23,353,324 shares in United Airlines, representing a 0.81% position in the firm's portfolio and accounting for 7.12% of the airline's shares.

PRIMECAP Management Reduces Stake in Rhythm Pharmaceuticals

PRIMECAP Management (Trades, Portfolio), a notable investment firm, has recently adjusted its investment portfolio by reducing its stake in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM). This move, executed on December 31, 2023, reflects the firm's ongoing portfolio management strategy and its assessment of RYTM's investment potential.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.